TI
ANIK icon

Trigran Investments’s Anika Therapeutics ANIK Stock Holding History

Trigran Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-168,400
Closed -$1.62M – 18
2025
Q4 		$1.62M Sell
168,400
-1,452,815
-90% -$13.9M 0.32% 16
2025
Q3 		$15.2M Sell
1,621,215
-415,296
-20% -$3.97M 2.76% 14
2025
Q2 		$21.5M Sell
2,036,511
-5,342
-0.3% -$67.4K 3.74% 13
2025
Q1 		$30.7M Buy
2,041,853
+20,075
+1% +$334K 4.52% 12
2024
Q4 		$33.3M Sell
2,021,778
-102,682
-5% -$2.03M 3.83% 13
2024
Q3 		$52.5M Sell
2,124,460
-11,772
-0.6% -$305K 5.74% 8
2024
Q2 		$54.1M Buy
2,136,232
+63,808
+3% +$1.65M 5.66% 8
2024
Q1 		$52.6M Sell
2,072,424
-66,630
-3% -$1.61M 5.1% 9
2023
Q4 		$48.5M Sell
2,139,054
-77,965
-4% -$1.61M 4.67% 9
2023
Q3 		$41.3M Buy
2,217,019
+410,390
+23% +$8.51M 4.4% 11
2023
Q2 		$46.9M Buy
1,806,629
+208,015
+13% +$5.57M 4.53% 10
2023
Q1 		$45.9M Buy
1,598,614
+34,073
+2% +$1.01M 4.43% 11
2022
Q4 		$46.3M Buy
1,564,541
+72,449
+5% +$2.06M 4.64% 11
2022
Q3 		$35.5M Buy
1,492,092
+337,909
+29% +$7.78M 4.08% 12
2022
Q2 		$25.8M Buy
1,154,183
+199,384
+21% +$4.45M 3% 14
2022
Q1 		$24M Buy
954,799
+362,611
+61% +$11.1M 2.43% 17
2021
Q4 		$21.2M Buy
592,188
+165,595
+39% +$6.63M 2.03% 17
2021
Q3 		$18.2M Buy
426,593
+242,240
+131% +$9.98M 2% 16
2021
Q2 		$7.98M Buy
+184,353
New +$7.85M 0.88% 16

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Trigran Investments's ANIK Position: Q1 2026 in Review

Trigran Investments sold out of Anika Therapeutics (ANIK) in Q1 2026, closing a stake of 168,400 shares — an estimated $1.62M sold.

Trigran Investments first reported a position in ANIK in Q2 2021 and held it in 19 quarters. The position peaked at $54.1M in Q2 2024. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Trigran Investments reported no remaining Anika Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Trigran Investments sold 168,400 Anika Therapeutics shares in Q1 2026, an estimated $1.62M.
  • Trigran Investments first reported a position in Anika Therapeutics in Q2 2021 and held it in 19 quarters.
  • Trigran Investments's Anika Therapeutics position peaked at $54.1M in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Trigran Investments's 13F filing for Q1 2026, filed 13 May 2026.